Offer Erez Selected Research

Offer Erez Research Topics

Disease

58	Pre-Eclampsia (Preeclampsia) 07/2022 - 12/2005
47	Inflammation (Inflammations) 06/2022 - 06/2007
42	Infections 06/2022 - 10/2005
29	Premature Obstetric Labor (Premature Labor) 12/2021 - 10/2005
20	Chorioamnionitis 12/2022 - 09/2007
13	Pregnancy Complications 01/2020 - 01/2007
11	Fetal Death 07/2022 - 09/2007
10	Disseminated Intravascular Coagulation 09/2022 - 08/2009
10	Rupture 06/2022 - 01/2008
10	Preterm Premature Rupture of the Membranes 05/2015 - 10/2008
9	Premature Birth (Birth, Premature) 01/2021 - 03/2006
8	Pyelonephritis 07/2022 - 10/2007
8	Thrombosis (Thrombus) 01/2022 - 08/2009
7	Hemorrhage 12/2022 - 06/2007
7	Fetal Growth Retardation (Intrauterine Growth Retardation) 07/2022 - 01/2011
7	Overweight 01/2010 - 01/2007
6	Abruptio Placentae (Placental Abruption) 09/2022 - 08/2009
6	Hemolysis 09/2022 - 10/2015
6	Birth Weight (Birth Weights) 10/2021 - 01/2003
6	Insulin Resistance 02/2010 - 01/2007
5	HELLP Syndrome 09/2022 - 04/2017
5	Stillbirth 09/2022 - 10/2015
5	Hypertension (High Blood Pressure) 05/2021 - 08/2007
4	Postpartum Hemorrhage 12/2022 - 04/2015
4	Diabetes Mellitus 05/2021 - 01/2009
4	Gestational Diabetes (Gestational Diabetes Mellitus) 05/2021 - 01/2009
4	Obesity 01/2010 - 12/2008
3	Maternal Death 12/2022 - 03/2017
3	Eclampsia 09/2022 - 10/2015
3	Neoplasms (Cancer) 01/2020 - 05/2015
3	Thrombophilia 10/2019 - 09/2007
3	Oligohydramnios 07/2019 - 08/2007
3	Sepsis (Septicemia) 01/2018 - 02/2010
3	fetal inflammatory response syndrome 07/2017 - 09/2007
3	Placenta Previa 08/2015 - 08/2012
2	Suppuration 12/2022 - 05/2018
2	Acute fatty liver of pregnancy 01/2022 - 10/2015
2	Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced) 05/2021 - 01/2005
2	Autoimmune Diseases (Autoimmune Disease) 05/2021 - 07/2008
2	Uterine Hemorrhage (Uterine Bleeding) 05/2018 - 10/2015
2	Ischemia 01/2018 - 01/2006
2	Dystocia 12/2016 - 04/2008
2	Uterine Rupture 10/2015 - 06/2007

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 01/2020 - 07/2008
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2006
10	Dacarbazine (DIC)FDA LinkGeneric 09/2022 - 01/2014
10	Interleukin-6 (Interleukin 6)IBA 03/2021 - 09/2007
10	AdipokinesIBA 02/2010 - 01/2007
9	EnzymesIBA 09/2022 - 09/2008
9	CytokinesIBA 06/2022 - 10/2005
9	Thrombin FDA Link 01/2022 - 06/2008
9	InterleukinsIBA 12/2021 - 09/2008
8	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019 - 07/2007
8	AdiponectinIBA 02/2010 - 01/2007
7	Biological ProductsIBA 01/2020 - 06/2008
7	ChemokinesIBA 10/2017 - 11/2007
7	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2017 - 10/2006
6	Messenger RNA (mRNA)IBA 11/2021 - 07/2008
6	Thromboplastin (Tissue Factor)IBA 01/2019 - 10/2008
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 07/2007
5	Hemostatics (Antihemorrhagics)IBA 01/2022 - 10/2008
5	lipoprotein-associated coagulation inhibitor (TFPI)IBA 01/2019 - 10/2008
5	EndoglinIBA 12/2017 - 01/2008
5	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2017 - 01/2008
5	Nicotinamide PhosphoribosyltransferaseIBA 08/2010 - 01/2008
5	N 30IBA 08/2009 - 06/2007
4	Protein Isoforms (Isoforms)IBA 01/2019 - 01/2009
4	Complement System Proteins (Complement)IBA 01/2018 - 10/2008
4	plasma protein Z (protein Z)IBA 08/2009 - 06/2007
3	Particulate MatterIBA 12/2022 - 01/2020
3	CreatinineIBA 09/2022 - 01/2014
3	Antithrombin IIIIBA 01/2022 - 08/2009
3	ProteomeIBA 01/2019 - 06/2008
3	Galectins (Galectin)IBA 01/2019 - 01/2011
3	Anti-Bacterial Agents (Antibiotics)IBA 06/2018 - 03/2006
3	Matrix Metalloproteinase 8 (Neutrophil Collagenase)IBA 01/2018 - 01/2017
3	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 08/2008
3	Furylfuramide (AF2)IBA 04/2010 - 01/2008
2	Cell-Free Nucleic AcidsIBA 06/2022 - 01/2018
2	AntithrombinsIBA 01/2022 - 11/2009
2	Fibrinogen (Factor I)FDA Link 01/2022 - 01/2022
2	ProstaglandinsIBA 12/2021 - 12/2020
2	Fibronectins (Fibronectin)IBA 11/2021 - 06/2007
2	Progesterone FDA LinkGeneric 01/2021 - 01/2018
2	tissue-factor-pathway inhibitor 2 (PP5)IBA 01/2020 - 01/2019
2	AnticoagulantsIBA 10/2019 - 06/2015
2	A-factor (Streptomyces)IBA 06/2019 - 06/2008
2	InflammasomesIBA 04/2019 - 09/2008
2	Erythropoietin FDA Link 02/2019 - 12/2005
2	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2019 - 01/2017
2	Immunoglobulins (Immunoglobulin)IBA 01/2019 - 01/2017
2	LectinsIBA 01/2019 - 05/2015
2	Matrix Metalloproteinase 7 (Matrilysin)IBA 01/2019 - 01/2017
2	LigandsIBA 02/2018 - 10/2017
2	Matrix Metalloproteinases (MMPs)IBA 01/2018 - 01/2017
2	Magnesium Sulfate (Sulfate, Magnesium)FDA LinkGeneric 01/2017 - 01/2013

Therapy/Procedure

9	Cesarean Section (Caesarean Section) 12/2022 - 01/2003
5	Induced Labor 07/2022 - 12/2016
2	Therapeutics 10/2019 - 01/2015
2	Conservative Treatment 07/2019 - 06/2019